Soft Tissue Sarcoma Market Size, Share, Epidemiology, and Forecast 2030 Comprising less than 1% of all the adult malignancies, and inflicting pain in more than one body organ, the rarity and heterogeneity of sarcomas make it difficult to diagnose, treat and run clinical trials resulting in efficient outcomes.